Investment firm Baird has revised its price target for Cigna Corporation (CI, Financial), reducing it from $388 to $362. Despite this adjustment, the firm maintains an Outperform rating on the healthcare company's stock. Baird's decision reflects an anticipation of limited new investments into the managed care and healthcare facilities sector until uncertainties around policy matters are resolved.
The firm suggests that there are unlikely to be any upward revisions in the guidance from companies within the sector. This is attributed to a strategy of preserving conservatism and cushioning through 2025, as potential challenges related to Part D coverage and broader economic conditions could arise later this year.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 23 analysts, the average target price for The Cigna Group (CI, Financial) is $360.96 with a high estimate of $395.00 and a low estimate of $323.00. The average target implies an upside of 9.65% from the current price of $329.20. More detailed estimate data can be found on the The Cigna Group (CI) Forecast page.
Based on the consensus recommendation from 26 brokerage firms, The Cigna Group's (CI, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for The Cigna Group (CI, Financial) in one year is $445.56, suggesting a upside of 35.35% from the current price of $329.2. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the The Cigna Group (CI) Summary page.
